癌症治疗光动力疗法的最新研究:从基础研究到临床试验
1College of Pharmacy, Dongduk Women's University, Seoul 02748, Republic of Korea.
Pharmaceutics
|September 28, 2023
概括
光动力疗法 (PDT) 是一种有前途的,最少侵入性的癌症治疗方法. 研究表明PDT在肺癌,头癌,皮肤癌,前列腺癌和乳腺癌中的有效性,目前正在进行试验,探索新的光敏感剂.
科学领域:
- 在瘤学瘤学.
- 摄影化学的使用.
- 医疗技术 医疗技术 医学技术
背景情况:
- 光动力疗法 (PDT) 是一种新兴的,不那么侵入性的癌症治疗方法.
- PDT利用光敏感剂,光和氧气产生细胞毒性作用.
- 显著的研究正在推动PDT用于各种瘤学应用.
研究的目的:
- 审查癌症治疗光动力疗法 (PDT) 研究的最新趋势.
- 总结PDT在各种癌症类型中的应用和进展.
- 突出正在进行的临床试验和PDT的未来方向.
主要方法:
- 最近的临床前研究和临床试验的文献综述.
- 专注于PDT在肺,头,非黑色素瘤皮肤,前列腺和乳腺癌中的应用.
- 对各种光敏感剂及其有效性的分析.
主要成果:
- 在肺癌中,PDT使用甲和甲等药物显示出有前途.
- 有效的辅助性PDT用于头癌,包括喉癌.
- 报告了使用ALA衍生物治疗非黑色素瘤皮肤癌的成功PDT治疗.
- 前列腺癌和乳腺癌的研究重点是向光敏化剂.
结论:
- PDT 是一种不断发展和有前途的癌症治疗策略.
- 目前正在进行的研究涵盖基础科学到临床试验,探索新型光敏剂.
- PDT为个性化和向性的癌症疗法提供了潜力.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


